| Infection-Related Neoplasm studied in …STUDIED_INderived200 of 539show all (up to 200) |
|---|
| → studied in | NCT04231877Phase 1 · active not recruiting Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006518recruiting Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01676805recruiting Tissue Collection for Studies of Lymph Cancer · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02682667recruiting Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03300830recruiting Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03309033active not recruiting Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04577755Phase 2 · active not recruiting Pomalidomide Treatment in Patients With Kaposi Sarcoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Skin Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05907759Phase 2 · recruiting Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Primary Effusion Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06563479Phase 3 · recruiting A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04301076Phase 1 · recruiting Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL) · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Acute Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05814549active not recruiting A Study Using Human Papillomavirus (HPV) DNA Testing to Detect HPV-Related Oropharyngeal Cancer (OPC) · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06305676recruiting Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC) · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07060261NA · recruiting Pre-Op MRI on Margin Status for Transoral Robotic Surgery for HPV+ Tonsillar Squamous Cell Carcinoma · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07565740Phase 1 · recruiting Intranasal WSK-IM05 Vaccine Plus Tislelizumab as Neoadjuvant Therapy for HPV+ OPSCC · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07706673Phase 4 · enrolling by invitation ESCUDDO Long Term Follow Up · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05237947Phase 4 · active not recruiting Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Cervical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06898203NA · recruiting Precision Imaging to Evaluate Kaposi Sarcoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04902443Phase 1 · recruiting Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06708351NA · not yet recruiting Enhancing Cervical Cancer Screening and Treatment in Women Living With HIV in Kenya, the ENHANCE LINKAge Trial · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Cervical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06926062NA · recruiting Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07576725Phase 2 · not yet recruiting Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03418480Phase 1/Phase 2 · completed HARE-40: HPV Anti-CD40 RNA vaccinE · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03634267Phase 1 · terminated MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06949800Phase 2 · recruiting CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03036930Phase 2 · active not recruiting Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04255849Phase 3 · active not recruiting Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05510973NA · completed Evaluation of Advanced HIV Disease Differentiated Care Model in Malawi · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | AIDS-Related Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07513324Phase 2 · not yet recruiting Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0) · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05985681Phase 1 · recruiting Testing RG1-VLP Vaccine to Prevent HPV-related Cancers · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07104240NA · recruiting A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06790966Phase 3 · terminated Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01961063Phase 1 · active not recruiting Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | AIDS-Related Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06375122recruiting Natural History Study of Kaposi Sarcoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07797738NA · not yet recruiting Prognostic Biomarkers for Patients With Human Papillomavirus (HPV) Positive Oropharyngeal Squamous Cell Carcinoma · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05976828Phase 1 · active not recruiting IBRX-042 In Participants With HPV-Associated Tumors · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00867464active not recruiting Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Cervical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02659930Phase 1 · active not recruiting Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02911142Phase 1/Phase 2 · active not recruiting Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Primary Effusion Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06016920Phase 1/Phase 2 · recruiting Safety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell Carcinoma · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06628570NA · recruiting Screening Strategies Among High-risk Populations for Anal Cancer · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07388563Phase 1 · suspended Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04742387active not recruiting Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04941274Phase 1/Phase 2 · recruiting Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07308886Phase 2 · recruiting Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV) · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04303117Phase 1/Phase 2 · recruiting PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05074264NA · active not recruiting Screening Algorithms for Cervical and Anal High-Grade Squamous Intraepithelial Lesions in People With HIV in Mexico and Puerto Rico · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | AIDS-Related Anal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03113500Phase 2 · active not recruiting Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06651957active not recruiting Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH) · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07768787completed Validation of Vaginal Self-Sampling With the Abbott Multi-Collect Swab for HPV Screening in Women Aged 30 to 64 Years · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Cervical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04920344Phase 2 · active not recruiting Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05510908completed Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | AIDS-Related Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07418034Phase 2 · not yet recruiting A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED) · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07425054Phase 2 · recruiting ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07649304Phase 1 · not yet recruiting AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study") · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | AIDS-Related Diffuse Large B-cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05859074Phase 1 · recruiting A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03220022Phase 1 · active not recruiting Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | AIDS-Related Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05119036NA · completed Adjuvant Treatment Deintensification After Transoral Surgery for Human Papillomavirus-Positive Squamous Cell Carcinoma · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05797662Phase 2 · not yet recruiting A Study of Propranolol to Treat Kaposi Sarcoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06600568recruiting Novel Therapeutic Approach for Human T-cell Malignancies · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04502407Phase 2 · active not recruiting Trial of De-Intensified Post-operative Chemoradiation Following Robotic Surgery for HPV-positive Oropharyngeal Cancer · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04900623Phase 2 · recruiting Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06115772recruiting Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06607874not yet recruiting Self-Collection for Cervical Cancer Screening and HPV Vaccination for Cancer Prevention Among Women in Emergency Care in Northeast Florida · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Cervical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03984448Phase 2/Phase 3 · active not recruiting Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006436Phase 2 · completed EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | AIDS-Related Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07172256Phase 2 · recruiting CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03264131Phase 2 · completed BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07727642NA · recruiting Optimization of Antiretroviral Therapy in Patients With AIDS-Related Lymphoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | AIDS-Related Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05419089Phase 2 · recruiting The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial) · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05377827Phase 1 · suspended Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04703192Phase 2 · active not recruiting Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01) · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06810739NA · recruiting The Women's Screening and Self-Testing Program (PROMETA) Study · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Cervical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02568566Phase 2 · active not recruiting Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05077527Phase 1 · recruiting Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | AIDS-Related Diffuse Large B-cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07696169not yet recruiting Disease Evolution and Risk Factors of AIDS-related Prevalent Cancers · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04799275Phase 2/Phase 3 · active not recruiting Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06797986Phase 1/Phase 2 · recruiting A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC. · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07578467Phase 1/Phase 2 · not yet recruiting Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06741072Phase 1 · recruiting BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | EBV-Related Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04975698Phase 2 · completed HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903 · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | AIDS-Related Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01815749Phase 1 · active not recruiting Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Adult Grade III Lymphomatoid Granulomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04664179Phase 1 · recruiting EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | EBV-Related Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04925544Phase 2 · active not recruiting Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | EBV-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04929028Phase 2 · active not recruiting Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | AIDS-Related Anal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04452526NA · active not recruiting I Vaccinate: Testing Multi-Level Interventions to Improve HPV Vaccination · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05639972Phase 1/Phase 2 · recruiting E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Cervical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05686226Phase 2 · recruiting E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07186530NA · enrolling by invitation Offering HPV Self-Collection in Novel Healthcare Settings to Improve Uptake of Cervical Cancer Screening · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Cervical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01412515Phase 2 · terminated A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07628062Phase 2 · not yet recruiting Phase 2 Study of NAI, HPV Vaccine, and Nab-Paclitaxel in HPV-Positive Oropharyngeal Cancer Followed by De-Intensified Radiation Compared With Standard Chemoradiation · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07555431Phase 2 · recruiting Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02799485Phase 2 · completed sEphB4-HSA in Treating Patients With Kaposi Sarcoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Skin Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05663502recruiting Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04514484Phase 1 · active not recruiting Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV · condition mapped CURATED_BROADER · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07539454Phase 2 · not yet recruiting Nirogacestat in Patients With Kaposi Sarcoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | AIDS-Related Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05978141recruiting A Registry for People With T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06234748Phase 2 · active not recruiting Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07497607Phase 2 · recruiting Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04369937Phase 2 · completed HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for "Intermediate Risk" HPV-16-associated Head and Neck Squamous Cell Carcinoma · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03038672Phase 2 · active not recruiting Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05541016Phase 2 · recruiting De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05600842recruiting De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04927650active not recruiting Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07563023early Phase 1 · not yet recruiting Exploratory Study on the Treatment of EB Virus Positive HIV Associated Lymphoma With EBV mRNA Vaccine · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | AIDS-Related Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03799445Phase 2 · terminated Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05714657Phase 2 · active not recruiting Shortened Course Adjuvant Radiotherapy Following TORS · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07075328Phase 1/Phase 2 · recruiting A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05108870Phase 1/Phase 2 · active not recruiting TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06157151Phase 2 · recruiting PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07097363Phase 2 · recruiting Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05507541Phase 2 · active not recruiting TTI-622 in Combination With Pembrolizumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma · condition mapped CURATED_BROADER · 539 trials mapped (162 active) | — | — | EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03621696Phase 2 · completed Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: "The Minimalist Trial (MINT)" · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01384513Phase 2 · completed A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies · condition mapped CURATED_BROADER · 539 trials mapped (162 active) | — | — | Adult Grade III Lymphomatoid Granulomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02379520Phase 1 · completed HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06638931Phase 2 · recruiting Agnostic Therapy in Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07356245Phase 2 · recruiting Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05232851Phase 1/Phase 2 · active not recruiting A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06544265Phase 1 · recruiting SynKIR-310 for Relapsed/Refractory B-NHL · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03323463Phase 2 · active not recruiting Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03601806Phase 2 · completed Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Skin Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05307939Phase 2 · recruiting A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC) · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06445166Phase 2 · recruiting Propranolol for the Treatment of Kaposi Sarcoma in Adults · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05387915Phase 2 · active not recruiting Biomarker-Driven Radiation Therapy Dose Reduction After Transoral Robotic Surgery for the Treatment of HPV-Positive Oropharyngeal Cancer · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06751355recruiting Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility Trial · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06391814NA · completed Donor-Derived EBV-Specific T Cells for Life Threatening EBV-lymphoma (OLIP-EBV-TCL-01-HMR01) · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | EBV-Related Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02213913Phase 1/Phase 2 · completed Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Adult Grade III Lymphomatoid Granulomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02737046Phase 2 · completed Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06508138Phase 1 · enrolling by invitation Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood Collection · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05934448Phase 2 · recruiting Pembro Plus CAR T-cell Therapy in R/R in PMBCL · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06698003Phase 2 · recruiting A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1 · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04857528recruiting Detecting HPV DNA in Anal and Cervical Cancers · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04988074Phase 2 · recruiting Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04305691Phase 2 · recruiting Trial of Ixazomib for Kaposi Sarcoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04362007Phase 1/Phase 2 · terminated A Phase I/II Study of ASTX660 in Patients With Relapsed or Refractory T-cell Lymphoma · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07063212Phase 2 · recruiting A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC) · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05544019Phase 1 · recruiting Study of SGR-1505 in Mature B-Cell Neoplasms · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03596918completed Evaluating Quality of Life in Patients With AIDS-Associated Kaposi Sarcoma Treated With Bleomycin and Vincristine · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | AIDS-Related Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06636734Phase 2 · recruiting Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04848064Phase 1 · recruiting Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma · condition mapped CURATED_BROADER · 539 trials mapped (162 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03260023Phase 1/Phase 2 · active not recruiting Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06480773active not recruiting Kaposi Sarcoma Chemotherapy and Research (KS-CARE) · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05784415completed Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | AIDS-Related Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06319963Phase 1/Phase 2 · recruiting A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Cervical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07381738Phase 2 · recruiting Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative Disorders · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | EBV-Related Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02065362Phase 1 · active not recruiting TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | EBV-Related Nasopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05583149Phase 2 · active not recruiting Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Adult Grade III Lymphomatoid Granulomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06834373Phase 2 · recruiting Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy · condition mapped CURATED_BROADER · 539 trials mapped (162 active) | — | — | EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05411237Phase 3 · not yet recruiting Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03978689Phase 1 · completed A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05846724Phase 2 · withdrawn Pembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi Sarcoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02408861Phase 1 · terminated Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05524025completed The SPOT-HPV Study · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05262010Phase 3 · recruiting A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06004011NA · recruiting AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW) · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04474821Phase 4 · completed HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03215719Phase 2 · recruiting Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06640283Phase 2 · recruiting Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03077451Phase 2 · completed Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma · condition mapped CURATED_BROADER · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06756269Phase 2 · recruiting To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04580446Phase 1 · completed HYHOPE: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06730412completed ctDNA Liquid Biopsy for Early Assessment of Residual Disease in HPV-associated Head and Neck Cancer (Clear-HPVca) · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02588651Phase 2 · completed A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL) · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05973487Phase 1 · active not recruiting A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Cervical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02337985Phase 1 · active not recruiting Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | AIDS-Related Burkitt Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06088381Phase 2 · recruiting Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL) · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05031897Phase 2 · recruiting Two Step Haplo With Radiation Conditioning · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05247853completed HPV Vaccine Effectiveness Study in Rwandan Women Living With HIV · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04260126Phase 2 · completed Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06925555Phase 2 · not yet recruiting Brentuximab Vedotin Combined With R-CHP in Newly Diagnosed EBV+ DLBCL-NOS · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04979000completed HPV in Sinonasal Ca: Retrospective Analysis Association of Human Papilloma Virus (HPV) Serology and Behavioral Risk Factors · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04180215Phase 1/Phase 2 · completed A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07159620Phase 2 · recruiting Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03180034Phase 4 · active not recruiting Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Cervical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01771107Phase 1/Phase 2 · completed Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | AIDS-Related Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06343311Phase 1/Phase 2 · recruiting T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | AIDS-Related Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03728881Phase 3 · completed Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Cervical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07087145recruiting Feasibility of HPV Testing With Mail-delivered Sample Collection Kits · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06307015NA · recruiting De-escalation of Radiation Dose in HPV-associated OPC Utilising FMISO PET (DE-RADIATE) · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05011058Phase 2 · terminated An Open-Label Phase 2 Trial of Nanatinostat Plus Valganciclovir in Patients With EBV+ Relapsed/Refractory Lymphomas · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03795610Phase 2 · completed IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06574087NA · recruiting Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases. · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05581550NA · completed Somatostatin Receptor Imaging in NPC, EBV Related Cancers · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | EBV-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07066982Phase 1/Phase 2 · recruiting Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05996783NA · active not recruiting Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Cervical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04142398withdrawn Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05567601Phase 1 · completed Doxil/Caelyx BE Study · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | AIDS-Related Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03061435NA · recruiting Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06052033NA · recruiting Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Cervical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02823327terminated Clinical and Genomic Factors for Prognosis of AIDS Primary Effusion Lymphoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | AIDS-Related Primary Effusion Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03944915Phase 2 · completed De-Escalation Therapy for Human Papillomavirus Negative Disease · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03107182Phase 2 · completed Chemotherapy and Locoregional Therapy Trial (Surgery or Radiation) for Patients With Head and Neck Cancer · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01184885early Phase 1 · completed A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04301011Phase 1 · terminated Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05608369Phase 2 · withdrawn Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03749707NA · completed HPV in Sentinel Lymph Nodes of Cervical Cancer Patients · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Cervical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03749720NA · completed HPV in Blood Samples From Cervical Cancer Patients. · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05284877recruiting The Organ Transplant Recipient HPV and Skin Cancer Study · condition mapped ALIAS · 539 trials mapped (162 active) | — | — | Human Papillomavirus-Related Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02631746Phase 2 · completed Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma · condition mapped ONTOLOGY_EXACT · 539 trials mapped (162 active) | — | — | Acute Adult T-Cell Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |